KCT0002038招募中未知
Response-based treatment of high-risk neuroblastoma
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 54
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- o Limit 至 o Limit（—）
- 性别
- All
入选标准
- •1. Patients with newly diagnosed high risk neuroblastoma
- •2. Patients with measurable or evaluable disease
- •3. Patients with informed consent
排除标准
- •1. Patients with progressive disease or relapse
- •2. Patients who underwent high dose chemotherapy before
- •3. Patients with organ dysfunction as follows (creatinine elevation > 3 x upper limit of normal, Total bilirubin > 3 x upper limit of normal, aspartate transaminase/alanine transaminase > 5 x upper limit of normal), ejection fraction <40%)
- •4. Pregnant or nursing women
研究者
相似试验
Unknown
2 期
Response-based Treatment of High-risk NeuroblastomaNewly Diagnosed High Risk NeuroblastomaNCT02771743Samsung Medical Center54
已完成
不适用
ovel treatment for refractory neuroblastoma by using poliovirus; phase I clinical trialrefractory neuroblastomaJPRN-UMIN000029816Mie University3
进行中（未招募）
1 期
Study for the low and intermediate risk NeuroblastomaINTERMEDIATE AND LOW RISK NEUROBLASTOMAMedDRA version: 20.0Level: PTClassification code 10029260Term: NeuroblastomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2010-021396-81-PTInstituto de Investigación Sanitaria La Fe de Valencia520
已完成
2 期
Combination Chemotherapy or Observation Following Surgery in Treating Infants With NeuroblastomaNeuroblastomaNCT00002803Children's Hospital Medical Center, Cincinnati44
进行中（未招募）
1 期
Engineered Neuroblastoma Cellular Immunotherapy (ENCIT)-01GanglioneuroblastomaNeuroblastomaNCT02311621Seattle Children's Hospital65